Cosmetic Dermatology Faculty

Abel Torres

Abel Torres MD, JD, MBA, FAAD, FACMS

Chairman & Professor
Phone: (352) 594-1919
  • Oct 2020 – Feb 2022
    Randomized, Double-Blind, Placebo-Controlled Trial to Evaluate the Efficacy and Safety of Lebrikizumab in when used in Combination with Topical Corticosteroid Treatment in Patients with Moderate-to-Severe Atopic Dermatitis
    SYNEOS HEALTH · Principal Investigator
  • Sep 2018 ACTIVE
    A randomized, double-blind, vehicle-controlled multicenter phase III study to evaluate the safety and efficacy of BF-200 ALA (Ameluz) and BF-RhodoLED in the treatment of superficial basal cell carcinoma with photodynamic therapy
    BIOFRONTERA BIOSCIENCE GMBH · Principal Investigator